SCHEMBL19081453

SCHEMBL19081453

c1ccc2c(-c3c4ccccc4c(-c4c5oc6ccccc6c5cc5c4oc4c6ccccc6ccc54)c4ccccc34)cccc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.41
CYP1A1 P04798 4/20 0.38
CYP1A2 P05177 4/20 0.38
CYP1B1 Q16678 4/20 0.38
CYP3A4 P08684 2/20 0.38
TSHR P16473 2/20 0.38
CYP2C19 P33261 2/20 0.38
PRKDC P78527 2/20 0.38
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 3/20 0.37
HSD17B10 Q99714 3/20 0.37
MAPT P10636 2/20 0.37
GAA P10253 1/20 0.37
ARSA P15289 1/20 0.37
CDC25A P30304 1/20 0.37
CDC25C P30307 1/20 0.37
KMT2A Q03164 1/20 0.37
DYRK1A Q13627 1/20 0.37
AHR P35869 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10122340 0.92 ALOX5 (0.43) ALOX5PRKDCKDM4EALDH1A1HPGD
SCHEMBL20127637 0.91 ALOX5 (0.40) ALOX5CYP1A2TSHRCYP2C19KDM4E
SCHEMBL19081671 0.89 ALOX5 (0.41) ALOX5CYP1A1CYP1A2CYP1B1CYP3A4
SCHEMBL17943885 0.87 ALOX5 (0.46) ALOX5PRKDCKDM4EALDH1A1HPGD
SCHEMBL10122451 0.86 ALOX5 (0.47) ALOX5PRKDCKDM4EALDH1A1HPGD
SCHEMBL17944165 0.86 ALOX5 (0.47) ALOX5PRKDCKDM4EALDH1A1HPGD
SCHEMBL19076443 0.85 ALOX5 (0.45) ALOX5PRKDCKDM4EALDH1A1HPGD
SCHEMBL20127399 0.85 ALOX5 (0.43) ALOX5CYP1A1CYP1A2CYP1B1CYP3A4
SCHEMBL20334503 0.85 ALOX5 (0.46) ALOX5PRKDCKDM4EALDH1A1HPGD
SCHEMBL19081619 0.85 CYP1B1 (0.42) ALOX5CYP1A1CYP1A2CYP1B1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ALOX5 1939/4885CYP1A1 184/4885CYP1A2 659/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ALOX5 1939/4885CYP1A1 184/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.